Theranostics News and Research

RSS

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.

26 Jun 2019

Newly developed melanin nanoparticles could slow tumor growth

The dark skin pigment melanin protects us from the sun's damaging rays by absorbing light energy and converting it to heat.

5 Apr 2019

Researchers show potential of biomimicry to grow prevascularized tissues for cardiac patches

A team led by Feng Zhao, associate professor of biomedical engineering at Michigan Technological University, recently published two new papers on best practices in engineering prevascularized tissues.

29 Mar 2019

Newly engineered nanoscale protein micelles can be tracked by MRI

A team of researchers from New York University has engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging.

21 Mar 2019

New approach to creating 'theranostics' for targeting specific tumors, diseases

A City of Hope scientist and his colleagues have developed a user-friendly approach to creating "theranostics" - therapy combined with diagnostics - that target specific tumors and diseases.

6 Mar 2019

RWTH Aachen chooses MILabs’ hybrid OI/CT system to enhance molecular imaging research

RWTH Aachen University have chosen the MILabs high-resolution CT to further enhance its world-leading molecular imaging research.

26 Feb 2019

New findings could provide novel approach to target and destroy cancer cells

An unexpected finding in pre-clinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.

11 Feb 2019

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

4 Dec 2018

New approach targets matrix surrounding neurons to protect neurons after stroke

To protect neurons and limit the damage after a stroke, researchers from the CNRS, the University of Caen-Normandie, University Paris-Est Créteil, and the company OTR3 have pursued an innovative path: targeting the matrix that surrounds and supports brain cells.

15 Nov 2018

Cornell dots equipped with antibody fragments offer a new cancer weapon

Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.

12 Oct 2018

Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

At an exclusive event held at University of California, Irvine Applied Innovation Center, Lumitron Technologies, Inc. celebrated its arrival in the university's prestigious Research Park and introduced the gathered luminaries to the HyperVIEW system.

9 Oct 2018

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Emerging cancer nanotechnology enables target-delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side-effects due to the lesser accumulation in the critical organs.

25 Sep 2018

MILabs' VECTor6 system wins Commercial Innovation Award at WMIC 2018

MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018.

20 Sep 2018

Innovative platform developed to destroy cancer cells

The new treatment will serve as both diagnosis and treatment of malignant tumors. This breakthrough in the technologies of cancer diagnosis and treatment was made by an interdisciplinary Russian-German collaboration of chemists, physicists, and biologists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Research Medical University (RNRMU), and the University of Duisburg-Essen (Germany).

17 Aug 2018

Researchers find link between common 'harmless' virus and cardiovascular damage

Researchers from Brighton and Sussex Medical School have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

13 Aug 2018

Novel smart probe may improve post-surgical outcomes for cancer patients

A new Tel Aviv University study explores a novel smart probe for image-guided surgery that may dramatically improve post-surgical outcomes for cancer patients.

26 Jun 2018

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Biophysicists have developed a method for modifying the surface of micro- and nanoparticles — tiny structures measuring between a thousandth and a millionth of a millimeter — by covering them with biological molecules. Engineered in this way, the particles can serve as both therapeutic and diagnostic agents, delivering drugs to cancer cells.

19 Jun 2018

MILabs' new VECTor5PET/SPECT/OI/CT system installed at TUM campus in Garching

A MILabs VECTor5PET/SPECT/OI/CT system has been installed at the Chair of Pharmaceutical Radiochemistry on the TUM Campus in Garching. Under the direction of Prof. Hans-Jurgen Wester, this institute has established a broad and internationally renowned radiopharmaceutical research program, consisting of fundamental tracer development, innovative radiolabeling strategies, and the preclinical and clinical assessment of new tracers.

31 May 2018

Researchers develop new method to study activity of inflammatory cells

The process that the body sets in motion in the event of inflammation is complex, but also impressive. The main role here is played by immune cells migrating from the blood into the tissue to fight the inflammation.

17 Apr 2018

Nanomedicine platform can guide doctors to remove tumors and kill malignant cells

Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.

21 Dec 2017